vs

Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $56.4M, roughly 1.4× KINGSTONE COMPANIES, INC.). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs 7.4%, a 18.8% gap on every dollar of revenue. On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs 25.5%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $9.7M). Over the past eight quarters, KINGSTONE COMPANIES, INC.'s revenue compounded faster (25.6% CAGR vs 22.7%).

Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

KINS vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.4× larger
VMD
$76.2M
$56.4M
KINS
Growing faster (revenue YoY)
KINS
KINS
+8.5% gap
KINS
34.0%
25.5%
VMD
Higher net margin
KINS
KINS
18.8% more per $
KINS
26.2%
7.4%
VMD
More free cash flow
KINS
KINS
$63.3M more FCF
KINS
$73.1M
$9.7M
VMD
Faster 2-yr revenue CAGR
KINS
KINS
Annualised
KINS
25.6%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KINS
KINS
VMD
VMD
Revenue
$56.4M
$76.2M
Net Profit
$14.8M
$5.6M
Gross Margin
57.9%
Operating Margin
32.7%
11.0%
Net Margin
26.2%
7.4%
Revenue YoY
34.0%
25.5%
Net Profit YoY
171.4%
30.7%
EPS (diluted)
$1.09
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KINS
KINS
VMD
VMD
Q4 25
$56.4M
$76.2M
Q3 25
$55.7M
$71.9M
Q2 25
$52.3M
$63.1M
Q1 25
$50.5M
$59.1M
Q4 24
$42.1M
$60.7M
Q3 24
$40.8M
$58.0M
Q2 24
$36.5M
$55.0M
Q1 24
$35.8M
$50.6M
Net Profit
KINS
KINS
VMD
VMD
Q4 25
$14.8M
$5.6M
Q3 25
$10.9M
$3.5M
Q2 25
$11.3M
$3.2M
Q1 25
$3.9M
$2.6M
Q4 24
$5.4M
$4.3M
Q3 24
$7.0M
$3.9M
Q2 24
$4.5M
$1.5M
Q1 24
$1.4M
$1.6M
Gross Margin
KINS
KINS
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
KINS
KINS
VMD
VMD
Q4 25
32.7%
11.0%
Q3 25
24.6%
7.8%
Q2 25
27.1%
8.1%
Q1 25
9.3%
6.5%
Q4 24
15.9%
10.6%
Q3 24
22.3%
9.7%
Q2 24
15.7%
6.6%
Q1 24
5.0%
4.4%
Net Margin
KINS
KINS
VMD
VMD
Q4 25
26.2%
7.4%
Q3 25
19.5%
4.9%
Q2 25
21.5%
5.0%
Q1 25
7.7%
4.4%
Q4 24
12.9%
7.1%
Q3 24
17.1%
6.7%
Q2 24
12.4%
2.7%
Q1 24
4.0%
3.2%
EPS (diluted)
KINS
KINS
VMD
VMD
Q4 25
$1.09
$0.14
Q3 25
$0.74
$0.09
Q2 25
$0.78
$0.08
Q1 25
$0.27
$0.06
Q4 24
$0.44
$0.10
Q3 24
$0.55
$0.10
Q2 24
$0.37
$0.04
Q1 24
$0.12
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KINS
KINS
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
$4.4M
Stockholders' EquityBook value
$122.7M
$141.5M
Total Assets
$453.4M
$199.2M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KINS
KINS
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Total Debt
KINS
KINS
VMD
VMD
Q4 25
$4.4M
Q3 25
$4.8M
Q2 25
$5.1M
Q1 25
$5.4M
Q4 24
$11.2M
Q3 24
$17.3M
Q2 24
$25.3M
Q1 24
$25.3M
Stockholders' Equity
KINS
KINS
VMD
VMD
Q4 25
$122.7M
$141.5M
Q3 25
$107.7M
$133.6M
Q2 25
$94.9M
$139.7M
Q1 25
$82.2M
$134.8M
Q4 24
$66.7M
$131.4M
Q3 24
$59.7M
$125.0M
Q2 24
$40.8M
$119.4M
Q1 24
$35.7M
$116.3M
Total Assets
KINS
KINS
VMD
VMD
Q4 25
$453.4M
$199.2M
Q3 25
$428.6M
$202.4M
Q2 25
$393.4M
$184.6M
Q1 25
$385.4M
$178.1M
Q4 24
$374.9M
$177.1M
Q3 24
$347.0M
$169.5M
Q2 24
$319.8M
$163.9M
Q1 24
$318.3M
$154.9M
Debt / Equity
KINS
KINS
VMD
VMD
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.05×
Q1 25
0.07×
Q4 24
0.17×
Q3 24
0.29×
Q2 24
0.62×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KINS
KINS
VMD
VMD
Operating Cash FlowLast quarter
$75.9M
$18.4M
Free Cash FlowOCF − Capex
$73.1M
$9.7M
FCF MarginFCF / Revenue
129.5%
12.7%
Capex IntensityCapex / Revenue
5.0%
11.5%
Cash ConversionOCF / Net Profit
5.14×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$124.0M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KINS
KINS
VMD
VMD
Q4 25
$75.9M
$18.4M
Q3 25
$25.9M
$18.4M
Q2 25
$9.3M
$12.3M
Q1 25
$17.9M
$2.9M
Q4 24
$57.9M
$15.0M
Q3 24
$21.7M
$12.7M
Q2 24
$7.1M
$10.2M
Q1 24
$6.1M
$1.2M
Free Cash Flow
KINS
KINS
VMD
VMD
Q4 25
$73.1M
$9.7M
Q3 25
$25.3M
$10.7M
Q2 25
$8.7M
$4.1M
Q1 25
$17.0M
$-12.6M
Q4 24
$55.6M
$3.2M
Q3 24
$21.0M
$1.7M
Q2 24
$6.6M
$1.2M
Q1 24
$5.6M
$-4.8M
FCF Margin
KINS
KINS
VMD
VMD
Q4 25
129.5%
12.7%
Q3 25
45.4%
14.9%
Q2 25
16.6%
6.5%
Q1 25
33.7%
-21.4%
Q4 24
132.1%
5.2%
Q3 24
51.6%
3.0%
Q2 24
18.1%
2.3%
Q1 24
15.5%
-9.5%
Capex Intensity
KINS
KINS
VMD
VMD
Q4 25
5.0%
11.5%
Q3 25
1.2%
10.6%
Q2 25
1.1%
12.9%
Q1 25
1.7%
26.2%
Q4 24
5.6%
19.5%
Q3 24
1.7%
19.0%
Q2 24
1.4%
16.3%
Q1 24
1.5%
11.9%
Cash Conversion
KINS
KINS
VMD
VMD
Q4 25
5.14×
3.27×
Q3 25
2.38×
5.23×
Q2 25
0.82×
3.88×
Q1 25
4.60×
1.09×
Q4 24
10.65×
3.47×
Q3 24
3.12×
3.29×
Q2 24
1.58×
6.94×
Q1 24
4.27×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons